26.05.2015 • NewsPeopleBYKDr Stephan Glander

Dr Stephan Glander New Division President of BYK Additives & Instruments

Dr Stephan Glander (46) has been appointed new managing director of BYK-Chemie and worldwide president of BYK Additives & Instruments, one of the divisions of Altana. He will take up these roles as of July 1, 2015, succeeding Dr Christoph Schlünken, who became a member of the Altana management board in November 2014.

Dr Glander brings many years of international management experience. With a PhD in chemistry and an MBA at Michigan State University, he held various management positions in major chemical companies such as Bayer. In his last role as managing director of the Engineering Plastics Division of Röchling, he had full responsibility for the Composites and Medical Plastics business units. Before that, from 2005 to 2012, he worked for Quadrant EPP in Switzerland as business line manager Advanced Engineering Plastics and was later promoted to global director Marketing & Technology.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.